nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0232	0.332	CbGbCtD
Sibutramine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0216	0.308	CbGbCtD
Sibutramine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0099	0.142	CbGbCtD
Sibutramine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00907	0.13	CbGbCtD
Sibutramine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00619	0.0885	CbGbCtD
Sibutramine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.000312	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00029	0.000312	CcSEcCtD
Sibutramine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000288	0.000309	CcSEcCtD
Sibutramine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000309	CcSEcCtD
Sibutramine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000309	CcSEcCtD
Sibutramine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000308	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000308	CcSEcCtD
Sibutramine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000305	CcSEcCtD
Sibutramine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.000304	CcSEcCtD
Sibutramine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000304	CcSEcCtD
Sibutramine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000302	CcSEcCtD
Sibutramine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000302	CcSEcCtD
Sibutramine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000302	CcSEcCtD
Sibutramine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000301	CcSEcCtD
Sibutramine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00028	0.000301	CcSEcCtD
Sibutramine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.0003	CcSEcCtD
Sibutramine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000299	CcSEcCtD
Sibutramine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000298	CcSEcCtD
Sibutramine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000277	0.000298	CcSEcCtD
Sibutramine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000277	0.000297	CcSEcCtD
Sibutramine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000297	CcSEcCtD
Sibutramine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000275	0.000295	CcSEcCtD
Sibutramine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000294	CcSEcCtD
Sibutramine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000274	0.000294	CcSEcCtD
Sibutramine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000294	CcSEcCtD
Sibutramine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000273	0.000293	CcSEcCtD
Sibutramine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000293	CcSEcCtD
Sibutramine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000271	0.000291	CcSEcCtD
Sibutramine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00029	CcSEcCtD
Sibutramine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00027	0.00029	CcSEcCtD
Sibutramine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000288	CcSEcCtD
Sibutramine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000268	0.000288	CcSEcCtD
Sibutramine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000286	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000266	0.000286	CcSEcCtD
Sibutramine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000286	CcSEcCtD
Sibutramine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000285	CcSEcCtD
Sibutramine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000284	CcSEcCtD
Sibutramine—Pain—Etoposide—peripheral nervous system neoplasm	0.000263	0.000283	CcSEcCtD
Sibutramine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000263	0.000283	CcSEcCtD
Sibutramine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000283	CcSEcCtD
Sibutramine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000283	CcSEcCtD
Sibutramine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000282	CcSEcCtD
Sibutramine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00028	CcSEcCtD
Sibutramine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00026	0.00028	CcSEcCtD
Sibutramine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000279	CcSEcCtD
Sibutramine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000279	CcSEcCtD
Sibutramine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000277	CcSEcCtD
Sibutramine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000276	CcSEcCtD
Sibutramine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000275	CcSEcCtD
Sibutramine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000274	CcSEcCtD
Sibutramine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000273	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000254	0.000273	CcSEcCtD
Sibutramine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000272	CcSEcCtD
Sibutramine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000253	0.000272	CcSEcCtD
Sibutramine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000271	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000252	0.000271	CcSEcCtD
Sibutramine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000251	0.00027	CcSEcCtD
Sibutramine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000251	0.00027	CcSEcCtD
Sibutramine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000267	CcSEcCtD
Sibutramine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000267	CcSEcCtD
Sibutramine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000248	0.000266	CcSEcCtD
Sibutramine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000266	CcSEcCtD
Sibutramine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.000266	CcSEcCtD
Sibutramine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000265	CcSEcCtD
Sibutramine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000264	CcSEcCtD
Sibutramine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000245	0.000263	CcSEcCtD
Sibutramine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000263	CcSEcCtD
Sibutramine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000262	CcSEcCtD
Sibutramine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000262	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000243	0.000262	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000243	0.000262	CcSEcCtD
Sibutramine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000262	CcSEcCtD
Sibutramine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000262	CcSEcCtD
Sibutramine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000261	CcSEcCtD
Sibutramine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00026	CcSEcCtD
Sibutramine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000242	0.00026	CcSEcCtD
Sibutramine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000241	0.000259	CcSEcCtD
Sibutramine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000259	CcSEcCtD
Sibutramine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000258	CcSEcCtD
Sibutramine—Rash—Vincristine—peripheral nervous system neoplasm	0.00024	0.000258	CcSEcCtD
Sibutramine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000239	0.000257	CcSEcCtD
Sibutramine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000257	CcSEcCtD
Sibutramine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000257	CcSEcCtD
Sibutramine—Headache—Vincristine—peripheral nervous system neoplasm	0.000238	0.000256	CcSEcCtD
Sibutramine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000254	CcSEcCtD
Sibutramine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000253	CcSEcCtD
Sibutramine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000234	0.000252	CcSEcCtD
Sibutramine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000252	CcSEcCtD
Sibutramine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00023	0.000247	CcSEcCtD
Sibutramine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000246	CcSEcCtD
Sibutramine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000244	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000227	0.000244	CcSEcCtD
Sibutramine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000244	CcSEcCtD
Sibutramine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000243	CcSEcCtD
Sibutramine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000226	0.000243	CcSEcCtD
Sibutramine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000242	CcSEcCtD
Sibutramine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000242	CcSEcCtD
Sibutramine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00024	CcSEcCtD
Sibutramine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.00024	CcSEcCtD
Sibutramine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000238	CcSEcCtD
Sibutramine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000221	0.000238	CcSEcCtD
Sibutramine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000237	CcSEcCtD
Sibutramine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000236	CcSEcCtD
Sibutramine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000234	CcSEcCtD
Sibutramine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000218	0.000234	CcSEcCtD
Sibutramine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000233	CcSEcCtD
Sibutramine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000233	CcSEcCtD
Sibutramine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000231	CcSEcCtD
Sibutramine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000214	0.00023	CcSEcCtD
Sibutramine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000228	CcSEcCtD
Sibutramine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000228	CcSEcCtD
Sibutramine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000227	CcSEcCtD
Sibutramine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000211	0.000227	CcSEcCtD
Sibutramine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000226	CcSEcCtD
Sibutramine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000225	CcSEcCtD
Sibutramine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000224	CcSEcCtD
Sibutramine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000223	CcSEcCtD
Sibutramine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000223	CcSEcCtD
Sibutramine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000221	CcSEcCtD
Sibutramine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00022	CcSEcCtD
Sibutramine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000219	CcSEcCtD
Sibutramine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000204	0.000219	CcSEcCtD
Sibutramine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000219	CcSEcCtD
Sibutramine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000218	CcSEcCtD
Sibutramine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000217	CcSEcCtD
Sibutramine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000216	CcSEcCtD
Sibutramine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000215	CcSEcCtD
Sibutramine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000214	CcSEcCtD
Sibutramine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000214	CcSEcCtD
Sibutramine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000211	CcSEcCtD
Sibutramine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000196	0.000211	CcSEcCtD
Sibutramine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00021	CcSEcCtD
Sibutramine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00021	CcSEcCtD
Sibutramine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000209	CcSEcCtD
Sibutramine—Rash—Etoposide—peripheral nervous system neoplasm	0.000194	0.000209	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000194	0.000209	CcSEcCtD
Sibutramine—Headache—Etoposide—peripheral nervous system neoplasm	0.000193	0.000207	CcSEcCtD
Sibutramine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000207	CcSEcCtD
Sibutramine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000206	CcSEcCtD
Sibutramine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000206	CcSEcCtD
Sibutramine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000205	CcSEcCtD
Sibutramine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000204	CcSEcCtD
Sibutramine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000204	CcSEcCtD
Sibutramine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000204	CcSEcCtD
Sibutramine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000204	CcSEcCtD
Sibutramine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000204	CcSEcCtD
Sibutramine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000202	CcSEcCtD
Sibutramine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000201	CcSEcCtD
Sibutramine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000186	0.0002	CcSEcCtD
Sibutramine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000198	CcSEcCtD
Sibutramine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000198	CcSEcCtD
Sibutramine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000197	CcSEcCtD
Sibutramine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000183	0.000197	CcSEcCtD
Sibutramine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000196	CcSEcCtD
Sibutramine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000195	CcSEcCtD
Sibutramine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000194	CcSEcCtD
Sibutramine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000194	CcSEcCtD
Sibutramine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000194	CcSEcCtD
Sibutramine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000194	CcSEcCtD
Sibutramine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000193	CcSEcCtD
Sibutramine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000193	CcSEcCtD
Sibutramine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000191	CcSEcCtD
Sibutramine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00019	CcSEcCtD
Sibutramine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000189	CcSEcCtD
Sibutramine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000189	CcSEcCtD
Sibutramine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000189	CcSEcCtD
Sibutramine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000188	CcSEcCtD
Sibutramine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000187	CcSEcCtD
Sibutramine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000186	CcSEcCtD
Sibutramine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000186	CcSEcCtD
Sibutramine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000186	CcSEcCtD
Sibutramine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000185	CcSEcCtD
Sibutramine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000184	CcSEcCtD
Sibutramine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000184	CcSEcCtD
Sibutramine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000183	CcSEcCtD
Sibutramine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000182	CcSEcCtD
Sibutramine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000182	CcSEcCtD
Sibutramine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000182	CcSEcCtD
Sibutramine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000181	CcSEcCtD
Sibutramine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00018	CcSEcCtD
Sibutramine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000179	CcSEcCtD
Sibutramine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000179	CcSEcCtD
Sibutramine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000179	CcSEcCtD
Sibutramine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000179	CcSEcCtD
Sibutramine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000179	CcSEcCtD
Sibutramine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000177	CcSEcCtD
Sibutramine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000177	CcSEcCtD
Sibutramine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000175	CcSEcCtD
Sibutramine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000173	CcSEcCtD
Sibutramine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000173	CcSEcCtD
Sibutramine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000172	CcSEcCtD
Sibutramine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000172	CcSEcCtD
Sibutramine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000171	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000169	CcSEcCtD
Sibutramine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000169	CcSEcCtD
Sibutramine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000168	CcSEcCtD
Sibutramine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000168	CcSEcCtD
Sibutramine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000168	CcSEcCtD
Sibutramine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000167	CcSEcCtD
Sibutramine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000167	CcSEcCtD
Sibutramine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000166	CcSEcCtD
Sibutramine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000165	CcSEcCtD
Sibutramine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000165	CcSEcCtD
Sibutramine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000164	CcSEcCtD
Sibutramine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000163	CcSEcCtD
Sibutramine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000161	CcSEcCtD
Sibutramine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00016	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000149	0.00016	CcSEcCtD
Sibutramine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000159	CcSEcCtD
Sibutramine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000159	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000156	CcSEcCtD
Sibutramine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000155	CcSEcCtD
Sibutramine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000154	CcSEcCtD
Sibutramine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000153	CcSEcCtD
Sibutramine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000153	CcSEcCtD
Sibutramine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000153	CcSEcCtD
Sibutramine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000152	CcSEcCtD
Sibutramine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000151	CcSEcCtD
Sibutramine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000149	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000148	CcSEcCtD
Sibutramine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000147	CcSEcCtD
Sibutramine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000147	CcSEcCtD
Sibutramine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000147	CcSEcCtD
Sibutramine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000147	CcSEcCtD
Sibutramine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000147	CcSEcCtD
Sibutramine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000142	CcSEcCtD
Sibutramine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00014	CcSEcCtD
Sibutramine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000137	CcSEcCtD
Sibutramine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000136	CcSEcCtD
Sibutramine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000136	CcSEcCtD
Sibutramine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000136	CcSEcCtD
Sibutramine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000133	CcSEcCtD
Sibutramine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000131	CcSEcCtD
Sibutramine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000127	CcSEcCtD
Sibutramine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000127	CcSEcCtD
Sibutramine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000123	CcSEcCtD
Sibutramine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000123	CcSEcCtD
Sibutramine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000121	CcSEcCtD
Sibutramine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000118	CcSEcCtD
Sibutramine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000117	CcSEcCtD
Sibutramine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000117	CcSEcCtD
Sibutramine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000117	CcSEcCtD
Sibutramine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000116	CcSEcCtD
Sibutramine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000114	CcSEcCtD
Sibutramine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00011	CcSEcCtD
Sibutramine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000109	CcSEcCtD
Sibutramine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000108	CcSEcCtD
Sibutramine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000108	CcSEcCtD
Sibutramine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000108	CcSEcCtD
Sibutramine—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000102	CcSEcCtD
